4
Changes in Ownership
Larimar Therapeutics, Inc. Filed Acc 0001062993-23-022200
Chief Development Officer bought 5,000 shares at $3.73 ($18,662)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Shankar Gopi Chief Development Officer | 2023-12-07 | Purchase | +5,000 | $3.73 | $18,662 | 5,000 | D: show line 1 in the form |
| Open-market purchases · 5,000 sh · avg $3.73 · $18,662 | |||||||
Loading xslF345X05/form4.xml…